Skip to main content
Log in

Power Doppler ultrasonography in the evaluation of infliximab treatment for sacroiliitis in patients with ankylosing spondylitis

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The aim of this study was to evaluate the feasibility of using power Doppler ultrasound (PDUS) to detect changes in the sacroiliac joint regions after infliximab (an anti-TNF-α blocker) treatment in active axial ankylosing spondylitis (AS) patients. A total of 110 sacroiliac joints in 55 patients with active AS were detected by PDUS before and after the infliximab treatment. The color flow signals inside the sacroiliac joints were observed, and the resistance index (RI) was measured. The clinical condition of the AS patients was improved compared with their condition before the infliximab treatment. Before the treatment, color flow signals were observed in 103 joints, and the mean RI value was 0.56 ± 0.06. Three months after the first infliximab treatment, color flow signals were observed in 50 joints, and the mean RI value was 0.87 ± 0.11. There were more blood flow signals in the sacroiliac joints before the infliximab treatment in patients with active AS (p < 0.01), and the mean RI value was higher after the infliximab treatment (p < 0.01). The blood flow signals in the sacroiliac joints became weaker or even disappeared and the RI values increased in patients with active sacroiliitis after infliximab treatment. This result shows that PDUS can be used in the follow-up of patients with axial AS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Tarhan F, Oru¨k G, Nifliog˘lu O, Ozer S Thyroid involvement in ankylosing spondylitis and relationship of thyroid dysfunction with anti-TNF a treatment. Rheumatol Int. doi:10.1007/s00296-012-2438-9

  2. Zeng QY, Chen R, Darmawan J, Xiao ZY, Chen SB, Wigley R et al (2008) Rheumatic diseases in China. Arthritis Res Ther 10:R17

    Article  PubMed  Google Scholar 

  3. Kabasakal Y, Kitapcioglu G, Yargucu F, Taylan A, Argin M, Gumusdis G (2009) Efficacy of SLZ and MTX (alone or combination) on the treatment of active sacroiliitis in early AS. Rheumatol Int 29(12):1523–1527

    Article  PubMed  CAS  Google Scholar 

  4. Arslan H, Sakarya ME, Adak B, Unal O, Sayarlioglu M (1999) Duplex and color Doppler sonographic findings in active sacroiliitis. AJR Am J Roentgenol 173:677–680

    Article  PubMed  CAS  Google Scholar 

  5. Zhu J, Xing C, Jiang Y, Hu Y, Hu B, Wang N (2012) Evaluation of complex appearance in vascularity of sacroiliac joint in ankylosing spondylitis by color Doppler ultrasonography. Rheumatol Int 32:69–72

    Article  PubMed  Google Scholar 

  6. Hu Y, Zhu J, Xue Q, Wang N, Hu B (2011) Scanning of the sacroiliac joint and enthuses by color Doppler ulstrasonography in patients with ankylosing spondylitis. J Rheumatol 38:1651–1655

    Article  PubMed  Google Scholar 

  7. van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368

    Article  PubMed  Google Scholar 

  8. Ryan LM, Carrera GF, Lightfoot RW Jr, Hoffman RG, Kozin F (1983) The radiographic diagnosis of sacroiliitis. A comparison of different views with computed tomograms of the sacroiliac joint. Arthritis Rheum 26:760–763

    Article  PubMed  CAS  Google Scholar 

  9. Mohammadi A, Ghasemi-Rad M, Aghdashi M, Mladkova N, Baradaransafa P (2012) Evaluation of disease activity in ankylosing spondylitis; diagnostic value of color Doppler ultrasonography. Skeletal Radiol. doi:10.1007/s00256-012-1412-7

    PubMed  Google Scholar 

  10. Huang F, Zhang LY, Zhang JL, Zhang FC, Liang DF, Deng XH et al (2006) A short-term efficacy and safety study of infliximab in active ankylosing spondylitis. Zhonghua Nei Ke Za Zhi 45:122–126

    PubMed  Google Scholar 

  11. Seo JS, Lee SS, Kim SI, Ryu WH, Sa KH, Kim SU et al (2005) Influence of VEGF gene polymorphisms on the severity of ankylosing spondylitis. Rheumatology 44:1299–1302

    Article  PubMed  CAS  Google Scholar 

  12. Braun J, Xiang J, Brandt J, Maetzel H, Haibel H, Wu P et al (2000) Treatment of spondyloarresults with antibodies against tumour necrosis factor α: first clinical and laboratory experiences. Ann Rheum Dis 59(Suppl 1):i85–i89

    Article  PubMed  CAS  Google Scholar 

  13. Unlü E, Pamuk ON, Cakir N (2007) Color and duplex Doppler sonography to detect sacroiliitis and spinal inflammation in ankylosing spondylitis. Can this method reveal response to anti-tumor necrosis factor therapy? J Rheumatol 34:110–116

    PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by National Natural Science Foundation of China (81171353/H1805). We affirm that we have no financial interest (payment, stock holdings, consultantship, honoraria, or employment) or relationship in the past years with any commercial company with potential interest in the subject matter enclosed in this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jiaan Zhu.

Additional information

L. Chen is co-first author for the article and she contributed equally.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jiang, Y., Chen, L., Zhu, J. et al. Power Doppler ultrasonography in the evaluation of infliximab treatment for sacroiliitis in patients with ankylosing spondylitis. Rheumatol Int 33, 2025–2029 (2013). https://doi.org/10.1007/s00296-013-2682-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-013-2682-7

Keywords

Navigation